Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001640334-25-000701
Filing Date
2025-04-28
Accepted
2025-04-25 17:48:07
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 lxrp_424b5.htm 424B5 321534
2 lxrp_424b5img2.jpg GRAPHIC 4787
3 lxrp_424b5img5.jpg GRAPHIC 5932
4 lxrp_424b5img6.jpg GRAPHIC 4785
5 lxrp_424b5img7.jpg GRAPHIC 4785
  Complete submission text file 0001640334-25-000701.txt   351165
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 424B5 | Act: 33 | File No.: 333-284407 | Film No.: 25875427
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)